tirzepatide vision loss TGA issues warning over GLP-1-based drugs' potential to cause rare eye disorder Tirzepatide Diabetic Retinopathy Risk: Monitoring

Laboratory research record on GLP-1S [PMID: 39047254] PubMed laboratory record discussing GLP-1S in a research context

Learn more about CI 77891 This ingredient is an synthetic emollient, emulsifier, and used as a surface treatment for pigment particles (like iron oxides or titanium dioxide)

Always monitor race time and/or set a low voltage warning on ESC (End voltage cannot be lower than 3.2v per cell)

Purely cosmetic weight loss is a gray zone because there is no FDA approval, but if it is improving the patients emotional and psychological well-being, it can still be a valid off-label benefit that may outweigh the risks (known or unknown)

The work highlights the potential for exploiting phenotypic heterogeneity to enhance bioproduction in yeast, offering an avenue for the further development of yeast cell factories